Loading...
JAK inhibitors suppress t(8;21) fusion protein-induced leukemia
Oncogenic mutations in components of the JAK/STAT pathway, including those in cytokine receptors and JAKs, lead to increased activity of downstream signaling and are frequently found in leukemia and other hematological disorders. Thus, small-molecule inhibitors of this pathway have been the focus of...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3987672/ https://ncbi.nlm.nih.gov/pubmed/23812420 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2013.197 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|